Innomed Technologies Receives ISO Quality System Certification

BOCA RATON, Fla.--(BUSINESS WIRE)--February 03, 2004 InnoMed Technologies announced today that it has received the International Standards Organization (ISO) Quality System Certification, a Quality Management System standard for companies which design, develop or produce medical devices. The company's facility in Greensburg, Penn., has received the ISO 13485 certification for the design and distribution of accessories to continuous positive airway pressure devices.

The intent of an ISO 13485 Quality Management System is to ensure to prospective customers and regulatory bodies that the goods and services offered by the organization will meet customer and regulatory requirements.

'We are very proud of this certification and are pleased that InnoMed's stringent standards are recognized both in the U.S. and internationally,' said Patrick Karem, C.E.O. of InnoMed Technologies. 'Our customers are pleased to know that InnoMed's design, development and production meet the highest standards.'

InnoMed designs, manufactures and markets the innovative Nasal-Aire, Nasal-Aire II and the Nasal-Aire II Critical Care. Independent clinical trials have shown that when patients are given a choice between using the Nasal-Aire or the three leading competitive masks, manufactured by Resmed, Inc. (NYSE:RMD), Respironics (Nasdaq:RESP), and Mallinckrodt, 98% of the time Nasal-Aire was chosen.

InnoMed Technologies, Inc., is a research-oriented, privately held, 21st Century medical technologies company. The company is poised to bring new and more effective medical products and devices to the public through a medical development and engineering team, as well as acquisitions of other medical related companies. InnoMed holds several patents and has several patents pending. More information regarding InnoMed Technologies is available at http://www.innomedinc.com.

A Private Securities Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain information included in this press release (as well as information included in written statements to be made) contain statements that are forward-looking, such as those relating to consummation of the transaction, anticipated future revenue of the Company, and success of current public offerings. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward looking statements.